A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s449139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Yan Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Chalcone, Down-Regulation, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong, 260071, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266071, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Shenzhen Luohu People's Hospital, Shenzhen, 518000, People's Republic of China.
- NMPA Key Laboratory for Quality Research and Evaluation of Traditional Marine Chinese Medicine, Qingdao, 266071, People's Republic of China.
- Department of Pharmacy, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266071, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Shanting District People's Hospital, Zaozhuang, 277200, People's Republic of China.
Zitieren
APA
Ma, Y., Cui, Q., Zhu, W., Wang, M., Zhai, L., Hu, W., Liu, D., Liu, M., Li, Y., Li, M., & Han, W. (2024). A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s449139
Vancouver
Ma Y, Cui Q, Zhu W, Wang M, Zhai L, Hu W, et al. A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s449139
BibTeX
@article{Ma2024,
author = {Ma, Yan and Cui, Qian and Zhu, Wenjing and Wang, Mei and Zhai, Li and Hu, Wenmin and Liu, Dongdong and Liu, Min and Li, Yongchun and Li, Meng and Han, Wei},
title = {A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s449139}
}
EUVIMED